Search Within

Ingo K Mellinghoff

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (8)
  3. Research Letter (2)
  4. Correspondence (1)
Groups
  1. GSK Faculty (27)
  2. Human Oncology and Pathogenesis Program (27)
  3. Population Sciences Research Program (27)
  4. Tow Center for Developmental Oncology (TCDO) (27)
  5. Epidemiology and Biostatistics (25)
  6. Biostatistics Service (23)

More Groups

People
  1. Katherine Panageas (19)
  2. Lisa De Angelis (18)
  3. Thomas Kaley (16)
  4. Christian Grommes (14)
  5. Anne Reiner (13)
  6. Craig Nolan (13)

More People

Years
  1. 2024 (5)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (5)

More Years

Publications
  1. Neuro-Oncology (7)
  2. Clinical Cancer Research (6)
  3. Journal of Clinical Oncology (2)
  4. Annals of Clinical and Translational Neurology (1)
  5. Blood (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. Oxford University Press (7)
  3. Nature Publishing Group (4)
  4. American Society of Clinical Oncology (3)
  5. American Society for Clinical Investigation (1)
  6. American Society of Hematology (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective germline sequencing of patients with gliomas, glioneuronal or neuronal tumors
    Meeting Abstract

    Lin, A.; Nandakumar, S.; Mehine, M.; Kemel, Y.; Mandelker, D.; Karajannis, M.; Sait, S. F.; Gavrilovic, I.; Pentsova, E.; Schaff, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Low-dose planned glucarpidase allows safe outpatient high-dose methotrexate treatment for CNS lymphoma
    Journal Article

    Schaff, L. R.; Carlow, D.; Schofield, R.; Wongchai, V.; Madzsar, J.; Hyde, A.; Reiner, A. S.; Panageas, K. S.; DeAngelis, L. M.; Mellinghoff, I. K.; more...
    JCO Oncology Practice (2024)

    Fulltext@MSK | Save
  • A phase II study assessing long-term response to ibrutinib monotherapy in recurrent or refractory CNS lymphoma
    Journal Article

    Grommes, C.; Nandakumar, S.; Schaff, L. R.; Gavrilovic, I.; Kaley, T. J.; Nolan, C. P.; Stone, J.; Thomas, A. A.; Tang, S. S.; Wolfe, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor volume growth as surrogate endpoint in IDH-mt glioma — Response
    Correspondence

    Bhatia, A.; Moreno, R.; Reiner, A. S.; Nandakumar, S.; Walch, H. S.; Malani, R.; Panageas, K. S.; Mellinghoff, I. K.; Bale, T. A.; Young, R. J.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma
    Journal Article

    Bhatia, A.; Moreno, R.; Reiner, A. S.; Nandakumar, S.; Walch, H. S.; Thomas, T. M.; Nicklin, P. J.; Choi, Y.; Skakodub, A.; Malani, R.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma
    Meeting Abstract

    Bhatia, A.; Moreno, R.; Reiner, A.; Nandakumar, S.; Walch, H.; Thomas, T.; Nicklin, P.; Choi, C.; Skakodub, A.; Malani, R.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma
    Journal Article

    Grommes, C.; Pentsova, E.; Schaff, L. R.; Nolan, C. P.; Kaley, T.; Reiner, A. S.; Panageas, K. S.; Mellinghoff, I. K.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
    Journal Article

    Chatila, W. K.; Walch, H.; Hechtman, J. F.; Moyer, S. M.; Sgambati, V.; Faleck, D. M.; Srivastava, A.; Tang, L.; Benhamida, J.; Ismailgeci, D.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • The CDK4/6 inhibitor abemaciclib in patients with recurrent meningioma and other primary CNS tumors
    Meeting Abstract

    Coffee, E.; Panageas, K.; Young, R.; Morrison, T.; Daher, A.; Grommes, C.; Gavrilovic, I. T.; Lin, A.; Miller, A.; Schaff, L.; more...
    Neuro-Oncology (2021)

    Fulltext@MSK | Save